XTL Biopharmaceuticals Ltd. (TLV:XTLB)
Israel · Delayed Price · Currency is ILS · Price in ILA 1.800
+0.100 (5.88%)
Jun 4, 2026, 10:15 AM IDT
XTL Biopharmaceuticals Employees
XTL Biopharmaceuticals had 10 employees as of December 31, 2024. The number of employees increased by 3 or 42.86% compared to the previous year.
Employees
10
Change
3
Growth
42.86%
Revenue / Employee
326.15K ILS
Profits / Employee
-2.13M ILS
Market Cap
16.09M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 10 | 3 | 42.86% | 10 | 0 |
| Dec 31, 2016 | 7 | 1 | 16.67% | 2 | 5 |
| Dec 31, 2015 | 6 | 1 | 20.00% | 3 | 3 |
| Dec 31, 2014 | 5 | - | - | 3 | 2 |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 52 |
| Bonus BioGroup | 42 |
| BioLineRx | 24 |
| Matricelf | 15 |
| Purple Biotech | 10 |
| Geffen Residence & Renewal | 6 |
| Can-Fite BioPharma | 5 |
| BioLight Life Sciences | 4 |
XTL Biopharmaceuticals News
- 12 days ago - XTL Biopharmaceuticals (XTLB) Faces Nasdaq Compliance Challenges Amid Stock Surge - GuruFocus
- 12 days ago - XTL Announces Receipt of Staff Delist Determination from Nasdaq - GlobeNewsWire
- 4 weeks ago - 3 Penny Stocks to Watch Now, 4/30/26 - TipRanks
- 5 weeks ago - XTL Biopharmaceuticals (XTLB) to Acquire Psyga Bio, Shares Surge 58.7% - GuruFocus
- 5 weeks ago - XTL Biopharmaceuticals to acquire Psyga Bio - TheFly
- 5 weeks ago - XTL Biopharmaceuticals to Acquire Psyga Bio, Establishing a Leading Psychedelic Biotechnology Platform with Advanced Clinical Pipeline, Licensed GMP Manufacturing and Proprietary Psilocybin Technologies - GlobeNewsWire
- 2 months ago - XTL Biopharmaceuticals trading halted, news pending - TheFly
- 2 months ago - XTL Biopharmaceuticals (XTLB) Adjusts ADS to Ordinary Share Ratio - GuruFocus